Last update 08 May 2025

Amlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Amlodipine/atorvastatin/valsartan, Atorvastatin/amlodipine/valsartan, Valsartan/atorvastatin/amlodipine
+ [2]
Target
AT1R x HMGCR x VDCCs
Action
antagonists, inhibitors, blockers
Mechanism
AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors), VDCCs blockers(Voltage-gated calcium channel blockers)
Therapeutic Areas
Cardiovascular DiseasesEndocrinology and Metabolic Disease
Active Indication
HyperlipidemiasHypertension
Inactive Indication-
Originator Organization
HK inno.N Corp.HK inno.N Corp.
Active Organization
HK inno.N Corp.HK inno.N Corp.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC26H31ClN2O8S
InChIKeyZPBWCRDSRKPIDG-UHFFFAOYSA-N
CAS Registry111470-99-6
View All Structures (4)

Related

1
Clinical Trials associated with Amlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan
NCT03657472
/ CompletedPhase 1
An Open-label, Randomized, Single-dose, 3-period Replicated Crossover Study to Compare the Pharmacokinetics and Safety Following Administration of CJ-30061 Alone and Co-administration of Amlodipine/Valsartan and Atorvastatin in Healthy Adult Volunteers
100 Clinical Results associated with Amlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan
Login to view more data
100 Translational Medicine associated with Amlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan
Login to view more data
100 Patents (Medical) associated with Amlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan
Login to view more data
100 Deals associated with Amlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HyperlipidemiasPhase 3-
HK inno.N Corp.HK inno.N Corp.
-
HypertensionPhase 3-
HK inno.N Corp.HK inno.N Corp.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free